Primary Record
Tesevatinib
- In stock
- 7,857 g
- Purity
- 98.9 %
- CAS
- 781613-23-8
Compound Identifiers & Properties
- CAS
- 781613-23-8
- PubChem CID
- 10458325
- SMILES
- CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC
- Canonical SMILES
- COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1C[C@@H]2CN(C)C[C@@H]2C1
Names & Synonyms
- Tesevatinib
- XL647
- XL-647
- tesevatinibum
- EXEL-7647
- 781613-23-8
- KD019
- XL-647, Primrose
- KD-019
- Tesevatinib [USAN:INN]
- UNII-F6XM2TN5A1
- RefChem:926721
- F6XM2TN5A1
- TESEVATINIB [INN]
- Tesevatinib (USAN/INN)
- TESEVATINIB [USAN]
- XL 647
- C24H25Cl2FN4O2
- D00ELE
- D06WRF
- EXEL 7647
- TESEVATINIB [WHO-DD]
- cc-224
- SCHEMBL721992
- SCHEMBL721993
- SCHEMBL721994
- KD 019
- KD-020
- EXEL7647
- GTPL7944
- orb1296161
- CHEMBL3544983
- CHEMBL6020102
- SCHEMBL29695787
- EX-A172
- QCR-153
- US9796704, Entry 9
- CHEBI:167674
- BDBM351283
- DTXSID201336925
- Tesevatinib;EXEL-7647;KD-019
- 2809AH
- BDBM50524283
- MFCD28501234
- NSC776762
- NSC784252
- NSC800946
- SAR245408
- ZINC38912363
- 651031-01-5
- AKOS027255007
- ZINC101781468
- ZINC114456300
- CS-3666
- DB11973
- NSC-776762
- NSC-784252
- NSC-800946
- CID10458325
- NCGC00347284-03
- NCGC00347284-04
- NCGC00390607-01
- NCGC00390607-02
- NCGC00390607-03
- AS-55834
- CID 10458325
- FX103992
- HY-13314
- AB0095021
- FT-0773855
- NS00073367
- XL-647;EXEL-7647;KD-019
- D11772
- Z-3098
- 7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- 204618-EP2277867A2
- BRD-K03765900-001-01-9
- Q27089251
- Q27277731
- N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- Renal system agent (polycystic kidney disease), Primrose
- 3-[(Z)-[(5Z)-5-benzylidene-4-methyl-3,6-dioxopiperazin-2-ylidene]methyl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]benzamide
- N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)-4-quinazolinamine
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3ar,6as)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)quinazolin-4-amine
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- 781613-23-8 (or 874286-84-7)
- 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta(c)pyrrol-5-yl)methoxy)-
- 7-[[(3aR,6aS)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
- 1000599-06-3
- 4-QUINAZOLINAMINE, N-(3,4-DICHLORO-2-FLUOROPHENYL)-6-METHOXY-7-(((3A.ALPHA.,5.BETA.,6A.ALPHA.)-OCTAHYDRO-2-METHYLCYCLOPENTA(C)PYRROL-5-YL)METHOXY)-
- 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aa,5a,6aa)-octahydro- 2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- 4-quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aa,5beta,6aa)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- 40779-26-8
- 7-{[(3aR,5R,6aS)-2-methyl-octahydrocyclopenta[c]pyrrol-5-yl]methoxy}-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- 7-{[(3aR,6aS)-2-methyl-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy}-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- 874286-84-7
- N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-{[(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy}quinazolin-4-amine
- N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-{[(3ar,6as)-2-methylo Ctahydrocyclopenta[c]pyrrol-5-yl]methoxy}-4-quinazolinamine
- N-(3,4-dichloro-2-fluorophenyl)-7- ({[(3aR,5s,6aS)-2- methyloctahydrocyclopenta[c]pyrrol-5- yl]methyl}oxy)-6-(methyloxy)quinazolin-4- amine
- N-(3,4-dichloro-2-fluorophenyl)-7-({[(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methyl}oxy)-6-(methyloxy)quinazolin-4-amine